Abstract
Background Impact and severity of coronavirus pandemic on health infrastructure vary across countries. We examine the role percentage health expenditure plays in various countries in terms of their preparedness and see how countries improved their public health policy in the first and second wave of the coronavirus pandemic;
Methods We considered the infectious period during the first and second wave of 195 countries with their Current Health Expenditure as Gross Domestic Product percentage (CHE/GDP). Exponential model was used to calculate the slope of the regression line while the ARIMA model was used to calculate the initial autocorrelation slope and also to forecast new cases for both waves. The relationship between epidemiologic and CHE/GDP data was used for processing ordinary least square multivariate modeling and classifying countries into different groups using PC analysis, K-means and Hierarchical clustering;
Results Results show that some countries with high CHE/GDP improved their public health strategy against virus during the second wave of the pandemic;
Conclusions Results revealed that countries who spend more on health infrastructure improved in the tackling of the pandemic in the second wave as they were worst hit in the first wave. This research will help countries to decide on how to increase their CHE/GDP in order to tackle properly other pandemic waves of the present Covid-19 outbreak and future diseases that may occur. We are also opening up a debate on the crucial role socio-economic determinants play during the exponential phase of the pandemic modelling.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding sources
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No IRB nor ethics committee was necessary, because the data used are all coming from public databases
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Kayode.Oshinubi{at}univ-grenoble-alpes.fr, Mustapha.Rachdi{at}univ-grenoble-alpes.fr, Jacques.Demongeot{at}univ-grenoble-alpes.fr
Data Availability
All the data are coming from public databases
Abbreviations
- ARIMAF
- Opposite autocorrelation slope for first wave
- ARIMAS
- Opposite autocorrelation slope for second wave
- SecondR
- Maximum R0 for second wave from [3]
- SecondD
- Deterministic R0 for second wave from [2]
- FirstwaveR
- Maximum R0 for first wave from [3]
- FirstwaveD
- Deterministic R0 for second wave from [2]
- CHE/GDP
- Current Health Expenditure as Gross Domestic Product percentage [1]